CD8A and neoplasm: ER−breast cancers (BCs) and triple -negative breast cancers (TNBCs) also offer little to no IRF8 expression, indicating that impaired cGAS/STING signaling supports tumor growth and metastasis due to decreased antitumor CD8+T cell infiltration [102, 103].